If you’re attending HLTH, don’t miss your chance to hear from our CEO, Dr. Alicia Zhou, as she joins a panel focusing on the role if AI in transforming how we understand and treat disease. The panel will explore how organizations are using AI, molecular engineering, and real-world data to advance precision medicine.
Panel Details
The Hinge Moment:
Artificial Intelligence, Human Data, and Drug Development in the 21st Century
Speakers:
Dr. Alicia Zhou, CEO, Cancer Research Institute
Dr. Janet Jin, Exec Dir Clinical Biomarkers & Diagnostics, Amgen Business Performance
Dr. Milad Alucozai, Co-Founder, Revalia Bio
Sunday, October 19
10:45 AM – 11:25 AM
Venetian D
